Pharmacokinetics of Tedizolid in an Obese Patient after Bariatric Surgery.
Antimicrob Agents Chemother
; 62(4)2018 04.
Article
em En
| MEDLINE
| ID: mdl-29378714
ABSTRACT
An obese woman was treated with oral tedizolid 200 mg once daily for pseudoarthrosis 10 years after Roux-en-Y bypass surgery. Total plasma peak concentration was 2.12 mg/liter 3 h after intake, and area under the concentration-time curve from 0 to 24 h (AUC0-24) was 28.3 mg/liter · h. The AUC0-24/MIC ratio for unbound concentrations and for sensitive Staphylococcus and Streptococcus strains was ≥10.8, higher than the target ratio of 3. These results support the use of tedizolid without adjustment after bariatric surgery.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Tetrazóis
/
Oxazolidinonas
/
Cirurgia Bariátrica
/
Obesidade
Limite:
Aged
/
Female
/
Humans
Idioma:
En
Revista:
Antimicrob Agents Chemother
Ano de publicação:
2018
Tipo de documento:
Article
País de afiliação:
França